Recent Comments
    Categories

    Archive for the ‘STEM CELLS’ Category

    SIGHT IMPROVERED FOR BLIND PEOPLE BY GETTING STEM CELLS INJECTIONS

    Wednesday, January 25th, 2012

    STEM CELLS INJECTED FOR BLINDNESS WORKS

    EMBRYONIC stem cells have been used to treat human illness for the first time, improving the sight of two women with severe vision loss.

    The controversial development could give hope to hundreds of thousands of people suffering macular degeneration – one of the most common forms of blindness in First World countries – and has been hailed a historic step by stem cell scientists.

    In a US trial last year, two legally blind women reported sight improvements after receiving a small dose of embryonic stem cell transplantations in their eyes.

    Both had different forms of macular degeneration, a group of diseases that affect the retina, causing loss of central vision.

    After the transplant in July, the first woman, who suffers from dry age-related macular degeneration, went from being able to read 21 letters on a sight test chart to 28. The second woman, who has Stargardt’s disease, went from being unable to read any letters to reading five. While the scientists who conducted the study are cautious about the results, tests indicate that healthy cells have grown where the treatment was injected.

    They said the patients had shown no negative reactions.

    The study, reported in The Lancet this week, was led by Robert Lanza, the chief scientific officer at Advanced Cell Technology in the US – the stem cell company that funded the trial.

    The research has taken place amid debate about whether the stem cells should be used because they are derived from five- to six-day-old human embryos.

    The disease affects one in seven people over 50, the Macular Degeneration Foundation says.

    Sourced & published by Henry Sapiecha

    Share and Enjoy

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • StumbleUpon
    • Add to favorites
    • Email
    • RSS

    GIVING YOUR SKIN TO MAKE MORE BLOOD FOR YOU USING STEM CELLS

    Sunday, March 27th, 2011

    Making blood from human skin

    By Grant Banks

    03:48 November 14, 2010

    Blood transfusions may one day come from blood produced from a patient's skin

    Blood transfusions may one day come from blood produced from a patient’s skin

    A new technique that allows blood to be made directly from skin cells has been discovered. The pioneering approach by Canadian researchers uses human skin stem cells to create blood stem cells without an intermediate step that previously was thought necessary.

    Until now to make blood stem cells, the building blocks for a variety human cells (called pluripotent stem cells) have been used as a steppingstone a process. This has proven largely inefficient, but research led by Mick Bhatia, scientific director ofMcMaster’s Stem Cell and Cancer Research Instituteat the Michael G DeGroote School of Medicine, has shown that making blood from skin can be achieved in a one step process.

    Cynthia Dunbar, head of the molecular hematopoiesis at the U.S National Institutes of Health said: “Bhatia’s approach detours around the pluripotent stem cell stage and thus avoids many safety issues, increases efficiency, and also has the major benefit of producing adult-type l blood cells instead of fetal blood cells, a major advantage compared to the thus far disappointing attempts to produce blood cells from human embryonic stem cells or induced pluripotent stem cells.”

    The discovery was replicated several times over two years using human skin from both the young and the elderly to prove it works for any age of person.

    The approach could be used for creating blood for surgery or treating conditions like anemia from a patch of the patient’s skin. Other potential applications include generating bone marrow and improved treatment of leukaemia and other types of cancer, including solid tumors.

    “We have shown this works using human skin. We know how it works and believe we can even improve on the process,” Bhatia said. “We’ll now go on to work on developing other types of human cell types from skin, as we already have encouraging evidence.”

    “This finding will no doubt be met with excitement in the research and medical communities,” said Michael Rudnicki, director of The Stem Cell Network. “It’s been nearly 50 years since blood stem cells were first identified here in Canada and it’s fitting that this incredible new discovery should have happened here as well.”

    The research was published in Nature on November 7.

    Sourced & published by Henry Sapiecha

    Share and Enjoy

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • StumbleUpon
    • Add to favorites
    • Email
    • RSS

    EXTRACTED TEETH ARE NOW SAVED FOR THEIR STEM CELLS FOR FUTURE USE

    Monday, January 24th, 2011

    Teeth pulled out & being saved for their stem cells


    MIAMI (UPI) — A new medical movement has U.S. dentists extracting teeth for their stem cells they believe can someday be used to cure any number of ailments, experts say.

    Stem cells are spun out of extracted baby teeth, wisdom teeth and even healthy adult teeth, frozen to 100 degrees below zero and stored for possible future use, The Miami Herald reported Tuesday.

    Florida resident Naidelys Montoya is one of those taking advantage of the process.

    The Hialeah woman didn’t wait for her son’s baby teeth to fall out but took the boy to an oral surgeon to have two of the loose ones extracted for their stem cells in case her son Raul Estrada, 6, might need them for a future illness, she says.

    “I believe in this,” Montoya said. “I did as a precaution against things that could happen in the future.”

    Many question the procedure.

    It’s expensive, costing $590 upfront and $100 a year to store stem cells from up to four teeth for up to 20 years.

    And it’s speculative, with the first FDA-approved practical use of such stem cells likely years away.

    Still, supporters are confident in the worth of the process.

    “I can’t help but feel excitement for their potential use in regenerating different tissues in the human body,” Dr. Jeremy Mao, director of the Regenerative Medicine Laboratory at Columbia University, said.

    Mao also is chief science adviser to StemSave, a New York City company that freezes the stem cells and stores them for later use, the Herald reported.

    The American Dental Association, while cautiously optimistic about the potential of dental stem cells, urges parents to consider both the cost and the rarity of use.

    “That’s the question people have to ask themselves,” said Dr. Jeffrey Blum, the Miami Beach oral surgeon who pulled Raul Estrada’s teeth.

    “Am I saving this for no reason? Is it worth what I’m paying? Essentially it’s an insurance policy.”

    Copyright 2011 by United Press International

    Sourced & published by Henry Sapiecha


    Share and Enjoy

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • StumbleUpon
    • Add to favorites
    • Email
    • RSS

    RECYCLED LIPOSUCTION FAT INTO STEM CELL USE

    Thursday, December 23rd, 2010
    USING BODY FAT STEM CELLS

    TO RECONSTRUCT WORN BODY PARTS

    *Grow new breasts

    *Replace damaged tissues

    *Body parts grown on demand

    *No more organ transplants needed

    Body fat has the highest level of stem cells in the human body
    THIS IS EXCITING NEWS FOR THE FUTURE OF THE HUMAN RACE
    Stem cells from body fat promisingVIEW VIDEO HERE

    Stem cells from body fat promising

    Dec 17 – A San Diego-based company is breaking new ground in the field of regenerative medicine with a system that uses patients’ own body fat to generate stem cells and repair tissue and organs. Ben Gruber reports.

    Sourced & published by Henry Sapiecha

    Share and Enjoy

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • StumbleUpon
    • Add to favorites
    • Email
    • RSS

    THE REGENERATION OF THE HUMAN HEART & THE REGULAR REPLACEMENT OF BODY PARTS AS THEY WEAR OUT

    Friday, August 13th, 2010


    Cell reprogramming breakthrough could mend broken hearts

    Heart disease remains one the biggest killers in the Western world. When a heart attack or heart failure occurs, permanent damage often results, destroying live cells and leaving the patient with irreversible scarring. Now scientists at the Gladstone Institute of Cardiovascular Disease (GICD) have discovered a new technique to create healthy beating heart cells from structural cells, opening up the possibility of regenerating damaged hearts. Read More

    Received & published by Henry Sapiecha


    Share and Enjoy

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • StumbleUpon
    • Add to favorites
    • Email
    • RSS

    GROWING NEW CELLS ON DEMAND – REPLACEMNET THERAPHY FOR CANCEROUS CELLS TO BE REBORN

    Monday, August 2nd, 2010

    Scientists envision ‘growing’ new cells


    TORONTO (UPI) — Scientists in Toronto say they are studying human cell regeneration in hopes of discovering how the body grows tissues and organs damaged by disease.

    At Mount Sinai Hospital, Dr. Ian Rogers is developing a replacement pancreas to be grown in a lab and then placed in diabetes patients to restore insulin production, Canadian Broadcasting Corp. News reported Wednesday.

    Rogers’ team is building a pancreas out of a surgical sponge, a three-dimensional structure seeded with insulin-producing islet cells. The lab-grown pancreas would be placed under the skin of patients with Type 1 diabetes to produce insulin.

    Any condition where cells are damaged — from insulin-producing cells in diabetes to brain cells in Alzheimer’s and Parkinson’s disease, to retina cells in blindness, to damaged areas in the heart — could in theory be repaired, researcher Dr. Andras Nagy said.

    “If we can find a way to replace these cells back in to where (they’re) missing, we can envision a cure for these diseases which are currently devastating,” he said.

    For now, most of the work is still in the test tube and Petri dish stage in Toronto and other laboratories around the world, the CBC said.

    Copyright 2010 by United Press International

    Sourced & published by Henry Sapiecha

    Share and Enjoy

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • StumbleUpon
    • Add to favorites
    • Email
    • RSS

    STEM BASED THERAPHY & SPINAL CORD DAMAGE – A GREAT COMBO FOR A FIX

    Monday, August 2nd, 2010

    FDA: Stem cell trial can proceed


    WASHINGTON (UPI) — The Food and Drug Administration has given approval to proceed with the world’s first human clinical trial of a human embryonic stem cell-based therapy.

    Geron Corp., headquartered in Menlo Park, Calif., says it will proceed with its trial of GRNOPC1, a stem-cell therapy intended to treat patients with acute spinal cord injury, a company release said Friday.

    “We are pleased with the FDA’s decision to allow our planned clinical trial of GRNOPC1 in spinal cord injury to proceed,” Geron President and Chief Executive Officer Thomas B. Okarma said. “Our goals for the application of GRNOPC1 in subacute spinal cord injury are unchanged — to achieve restoration of spinal cord function by the injection of … progenitor (stem) cells directly into the lesion site of the patient’s injured spinal cord.”

    “The neurosurgical community is ready to begin the clinical testing of this new approach to treating devastating spinal cord injury,” said Richard Fessler, professor of neurological surgery at the Feinberg School of Medicine at Northwestern University. “If found to be safe and effective, the therapy would provide a viable treatment option for thousands of patients who suffer severe spinal cord injuries each year.”

    Copyright 2010 by United Press International

    Sourced & published by Henry Sapiechas

    Share and Enjoy

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • StumbleUpon
    • Add to favorites
    • Email
    • RSS

    STEM CELLS AND ARTERIAL PLAQUE REMEDY

    Tuesday, July 27th, 2010

    Nanotechnology and stem cells rejuvenate arteries

    A combination of nanotechnology and adult stem cells has been shown to destroy arterial plaque atherosclerosis in the hearts of pigs. Animals that received stem cells also showed signs of new blood vessel growth and restoration of artery function, according to the study reported at the American Heart Association’s Basic Cardiovascular Sciences 2010 Scientific Sessions.

    The study was conducted at the Department of Internal Medicine and Research Center of Regenerative Medicine, Ural State Medical Academy in Yekaterinburg, Russia. Nanoparticles were infused into the heart of pigs, along with adult stem cells, then heated by laser light until they burned away arterial plaque. The volume of plaque shrunk an average of 28.9 percent immediately after treatment across the three treatment groups, and six months later it had declined 56.8 percent on average. In the control group, plaque volume increased an average of 4.3 percent.

    “Biophotonics (light therapy), plasmonics (plasma therapy), stem cell therapy and nanotechnology might someday offer a completely novel treatment to reduce artery plaque build-up,” said lead author and research manager Alexandr Kharlamov. “Nanoburning in combination with stem cell treatment promises demolition of plaque and functional restoration of the vessel wall.”

    This new approach may one day replace angioplasty, a common treatment for atherosclerosis, in which a balloon-tipped catheter is threaded into a blocked artery and the balloon is inflated to restore blood flow. The balloon squeezes plaque against the artery wall, but does not eliminate it.

    Sourced & published by Henry Sapiecha

    Share and Enjoy

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • StumbleUpon
    • Add to favorites
    • Email
    • RSS

    GROWING NEW LUNGS ON A FRAME

    Tuesday, June 29th, 2010

    Scientists Grow New Lungs

    Using ‘Skeletons’ of Old Ones

    Science (June 28, 2010) — For someone with a severe, incurable lung disorder such as cystic fibrosis or chronic obstructive pulmonary disease, a lung transplant may be the only chance for survival. Unfortunately, it’s often not a very good chance. Matching donor lungs are rare, and many would-be recipients die waiting for the transplants that could save their lives.


    Such deaths could be prevented if it were possible to use stem cells to grow new lungs or lung tissue. Specialists in the emerging field of tissue engineering have been hard at work on this for years. But they’ve been frustrated by the problem of coaxing undifferentiated stem cells to develop into the specific cell types that populate different locations in the lung.

    Now, researchers from the University of Texas Medical Branch at Galveston have demonstrated a potentially revolutionary solution to this problem. As they describe in an article published electronically ahead of print by the journal Tissue Engineering Part A, they seeded mouse embryonic stem cells into “acellular” rat lungs — organs whose original cells had been destroyed by repeated cycles of freezing and thawing and exposure to detergent.

    The result: empty lung-shaped scaffolds of structural proteins on which the mouse stem cells thrived and differentiated into new cells appropriate to their specific locations.

    “In terms of different cell types, the lung is probably the most complex of all organs — the cells near the entrance are very different from those deep in the lung,” said Dr. Joaquin Cortiella, one of the article’s lead authors. “Our natural matrix generated the same pattern, with tracheal cells only in the trachea, alveoli-like cells in the alveoli, pneumocytes only in the distal lung, and definite transition zones between the bronchi and the alveoli.”

    Such “site-specific” cell development has never been seen before in a natural matrix, said professor Joan Nichols, another of the paper’s lead authors. The complexity gives the researchers hope that the concept could be scaled up to produce replacement tissues for humans — or used to create models to test therapies and diagnostic techniques for a variety of lung diseases.

    “If we can make a good lung for people, we can also make a good model for injury,” Nichols said. “We can create a fibrotic lung, or an emphysematous lung, and evaluate what’s happening with those, what the cells are doing, how well stem cell or other therapy works. We can see what happens in pneumonia, or what happens when you’ve got a hemorrhagic fever, or tuberculosis, or hantavirus — all the agents that target the lung and cause damage in the lung.”

    The researchers have already begun work on large-scale experiments, “decellularizing” pig lungs with an eye toward using them to produce larger samples of lung tissue that could lead to applications in humans. They’re also taking on the challenge of vascularization — stimulating the growth of blood vessels that will enable the engineered tissues to survive outside the special bioreactors that the researchers now use to keep them alive by bathing them in a life-sustaining cocktail of nutrients and oxygen.

    “People ask us why we’re doing the lung, because it’s so hard,” Cortiella said. “But the potential is so great, and the technology is here. It’s going to take time, but I think we’re going to create a system that works.”

    Other authors of the Tissue Engineering Part A paper are UTMB research associate Jean Niles, associate professor Gracie Vargas, medical student Sean Winston, graduate student Shannon Walls, summer research fellows Andrea Brettler and Jennifer Wang, Andrea Cantu of Stanford University and Dr. Anthony Pham of Brown Medical School

    Sourced & published by Henry Sapiecha

    Share and Enjoy

    • Facebook
    • Twitter
    • Delicious
    • Digg
    • StumbleUpon
    • Add to favorites
    • Email
    • RSS
    Bookmarks
    Sponsors